XML 31 R7.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Operating activities      
Net (loss) income $ (29,029) $ 1,891 $ (33,452)
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:      
Depreciation and amortization 285 178 366
Non-cash interest expense 0 26 108
Stock-based compensation expense 1,381 4,013 2,529
Change in fair value of warrant liability (5) (110) (3,104)
Loss (gain) from change in fair value of contingent consideration 9,100 (1,100) 0
Loss on extinguishment of debt 0 221 0
Gain on sale of equipment (108) (24) 0
Changes in operating assets and liabilities:      
Prepaid expenses and other assets 164 800 110
Restricted cash 0 84 0
Accounts payable (760) (742) (1,212)
Accrued expenses and other liabilities 1,746 (1,936) 226
Deferred revenue (425) 19 (100)
Due to related party (114) (698) 0
Net cash (used in) provided by operating activities (17,765) 2,622 (34,529)
Investing activities      
Cash acquired in acquisition 0 136 0
Net sales (purchases) of property and equipment 98 325 (287)
Net cash provided by (used in) investing activities 98 461 (287)
Financing activities      
Proceeds from issuance of notes payable, net of debt issuance costs 0 0 5,000
Payments on equipment financing and notes payable 0 (14,124) (877)
Proceeds from issuance of common stock and common stock warrants, net of issuance costs 6,908 0 12,650
Proceeds from exercise of common stock options and common stock warrants 85 269 63
Proceeds from sale of common stock pursuant to ESPP 12 35 0
Net cash provided by (used in) financing activities 7,005 (13,820) 16,836
Net decrease in cash and cash equivalents (10,662) (10,737) (17,980)
Cash and cash equivalents at beginning of period 25,342 36,079 54,059
Cash and cash equivalents at end of period 14,680 25,342 36,079
Supplemental non-cash investing and financing activities      
Common stock issued in connection with the acquisition (Note 3) 0 13,525 0
Fair value of assets acquired in the acquisition, excluding cash 0 79,366 0
Fair value of liabilities assumed in the acquisition 0 19,777 0
Adjustment to fair value of assets acquired and liabilities assumed during provisional period (Note 3) 14,600 0 0
Issuance of warrants to purchase common stock 2,679 0 328
Supplemental cash flow information      
Cash paid for interest $ 0 $ 663 $ 930